1. 15% of patients initiating PrEP had an alcohol use disorder diagnosis within 6 months. On
2. Only 8.46% of patients with AUD received an FDA-approved medication.
3. The underdiagnosis of AUD prior to PrEP initiation and undertreatment following initiation was highlighted.
4. The study emphasized integrating mental health assessments into regular care alongside PrEP services.
5. Improved screening and access to evidence-based treatments for AUD in this population is necessary to support PrEP adherence and HIV prevention efforts.

Source: JAMA Network Open